effects compared to chemical medicines. Many antidiabetic products of herbal origin are available in India. Hence, we planned to evaluate effect of one of them, that is, fenugreek (Trigonella foenumgraecum). These seeds have been shown to have an effect on cholesterol and blood sugar.
Introduction
Since a long time, diabetes has been treated with plant medicines. It is believed that herbal products have few side cholesterol absorption. 4-Hydroxy leucine found in these seeds stimulates insulin secretion in pancreas and lowers absorption of glucose. [7] Apart from effect on blood glucose and lipid profiles, this prized spice is an excellent source of minerals such as copper, potassium, calcium, iron, selenium, zinc, manganese, and magnesium. Potassium is an important component of cell and body fluids that helps control heart rate and blood pressure by counteracting on sodium. Iron is essential for red blood cells production and as a cofactor for cytochrome oxidase enzymes. It is also rich in many vital vitamins that are essential nutrients for optimum health, including thiamine, pyridoxine, folic acid, riboflavin, niacin, vitamin A, and vitamin C. This has been used in many traditional medicines as a laxative, a digestive, and a remedy for cough and bronchitis.
Materials and Methods
Design of the study was prospective and was carried out on 50 already diagnosed patients with type 2 DM attending outpatient department of MGM Medical College and LSK Hospital Kishanganj, Bihar. The age of the patients was 40-60 years. All the patients were duly informed about the research work, possible effects, and side effects of fenugreek. They participated with their own interest, and written informed consent was taken from everyone. The duration of this study was 2 months (8 weeks). Institutional ethics committee approval was obtained before the start of the study. Patients meeting these inclusion criteria were put on standard diet and exercise for 1 month. Then they were divided into two groups: group 1 patients were given the standard treatment protocol, that is, diet, exercise and 5 g fenugreek seed powder four times a day before meal for 8 weeks. Group 2 patients were given the usual treatment protocol, that is, diet, exercise, and oral hypoglycemic drugs, except fenugreek. Patients were assessed initially and then weekly for blood sugar fasting levels and on the end of eighth week for HbA 1 C and lipid profiles.
Inclusion Criteria

Method of Examination
Blood glucose fasting: by glucose oxidase method with StatFax 3300 (Ark Diagnostic Pvt. Ltd., Bangalore, India).
HbA 1 C: by DS5 Drew Scientific Machine (ion exchange chromatography; Drew Scientific Ltd., Cumbria, UK)
Lipid Profiles: reference values for plasma total cholesterol were obtained by using auto-analyzer systems to which either the ferric-chloride (sulfuric acid method) or Liebermann-Burchard test was adapted. A fluorometric analysis was used to determine triglyceride reference values. Plasma high-density lipoprotein (HDL) cholesterol determination done by the same procedures used for plasma total cholesterol, after precipitation of Apo-B-containing lipoproteins in whole plasma (low-density lipoprotein (LDL) and very low-density lipoprotein cholesterol) by heparin-manganese chloride. Lipoproteins can be separated by ultracentrifugation, precipitation, and electrophoresis. The quantitative reference method uses precipitation and ultracentrifugation sequentially to determine each lipoprotein component. Usually, measurement of plasma lipid level is sufficient for evaluations of patterns of lipoproteins elevations. Occasionally, paper electrophoresis of plasma is helpful.
Safety Profile
Blood urea, serum bilirubin, liver transaminases (AST, ALT), serum creatinine, and prothrombin time were checked weekly.
At the end of 8 weeks, all the results were collected and analyzed by a statistician. The data for statistical analysis were assessed using SPSS, version 16 (SPSS Inc., Chicago, IL). Numerical variables were recorded as mean±SD. Statistical significance was computed by unpaired t-test. The level of significance was fixed at 5% (p < 0.05). 
Results
In this study, 50 patients of known cases of type 2 DM were enrolled. They were divided into two groups before the study. One group was considered as cases (group 1) and other group as controls (group 2) (Figure 1 ). From the group 1 four subjects and from group 2 one subject withdrew themselves from the study. Results of this study have been shown in Tables 1-3 .
Discussion
It is a well-known fact that attainment of good glycemic control in patients with type 2 DM is not always adequate and may require some additional/alternative approach. This study was undertaken to evaluate the efficacy of fenugreek seeds for controlling glycemia and dyslipidemia in patients with type 2 DM. Various studies have been conducted to see the effect of high-fiber diet, fenugreek, and other herbal agents in the management of diabetes. In our study, intake of fenugreek seeds resulted in significant reduction in blood glucose (F), T-CH, LDL and triglycerides (TG) with significant increase in HDL. Although there was a beneficial effect on HbA 1 C, but statistically, it was not significant. This fact was also supported by the research study by Neelakantan et al. [8] The results of a study conducted by Zargar et al. [9] are very similar to that of this study. ICMR (Indian Council of Medical Research) in its bulletin described the alkaloids of fenugreek and also reported the antidiabetic action of fenugreek seeds.
[10] Similar results were also obtained by some other studies. [11] [12] [13] Italian herbalists frequently suggested fenugreek for glycemic control. [14] Studies in animals such as diabetic dogs and rats also showed that fenugreek seed intake increased insulin sensitivity and reduced blood glucose levels. [15] [16] [17] Lipidlowering effect of fenugreek may be an additional benefit in patients with type 2 DM with dyslipidemia. [18] [19] [20] El-Soud et al. [21] found in albino rats with experimental diabetes induced by streptozotocin that during diabetes liver shows decrease in weight due to enhanced catabolic processes such as glycogenolysis, lipolysis, and proteolysis, which is the outcome of lack of insulin and/or cellular glucose in liver cells. There is, however, an increase in kidney weight due to glucose excess and subsequent enhancement in glycogen synthesis, protein synthesis, and lipogenesis. [22] These changes may lead to serious microvascular renal complications involving a series of metabolic changes in the pathogenesis of diabetic nephropathy. [23] Studies indicated treatment of diabetic rats with fenugreek alkaloids significantly prevented the alteration in liver and kidney weight and pathology with return to their normal texture. [24] The principal hypoglycemic alkaloid in fenugreek seed is trigonelline (0.2-0.36%). However one study has shown that the purified hypoglycemic principle of fenugreek seeds is different from that of alkaloid trigonelline based on UV and IR absorption spectra, thin-layer chromatography, and high-performance liquid chromatography criteria. This highly active hypoglycemic principle isolated from fenugreek seed increases glucose-induced serum insulin levels and improves glucose tolerance after treatment with a dose of 100 mg/kg in alloxan-induced diabetic rabbits. There was an improvement in glycosylated hemoglobin and serum lipid profile. There was an increase in the activity of the key enzymes of glycolysis in muscle but not in the liver. Slight inhibition in the activity of gluconeogenic enzymes was also noticed, proving thereby that the active compound acts at both pancreatic and extrapancreatic sites. [25] Thus, our studies in humans confirm that crude fenugreek seeds including trigonelline and others do have a good overall effect on DM and its complications.
Conclusion
We show that fenugreek seeds may be a promising additional option for management of diabetes as these are widely available at low cost in poor countries like India but certain things should kept be in mind before prescribing fenugreek seeds to diabetic patients:
1. It must be standardized and tested for its composition 2. It should be consumed 20 min before intake of food every time (breakfast, lunch, dinner, and snacks) 3. The amount should be same even if small meal or snack (i.e., 5 g) is taken 4. If on current oral medications, use of this herbs should be at least 2 h before or after these drugs because fenugreek fiber has the potential to interfere with the absorption of oral medication due to its mucilaginous contents (which gives it a moist and sticky texture) 5. Fenugreek use in pregnancy is not recommended as it has the potential to induce labor 6. Fenugreek seeds DO NOT cure diabetes but helps in blood sugar control
